Merus BV

Company Profile

Merus BV had its IPO on 2016-05-19 under the ticker symbol MRUS.

The company operates in the Healthcare sector and Biotechnology industry. Merus BV has a staff strength of 164 employees.

Stock update

Shares of Merus BV opened at $23.9 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $23.88 - $24.63, and closed at $24.39.

This is a +1.84% increase from the previous day's closing price.

A total volume of 324,852 shares were traded at the close of the day’s session.

In the last one week, shares of Merus BV have increased by +5.04%.

Merus BV's Key Ratios

Merus BV has a market cap of $1.38 billion, indicating a price to book ratio of 2.1479 and a price to sales ratio of 13.1869.

In the last 12-months Merus BV’s revenue was $41.22 million with a gross profit of $-107838000 and an EBITDA of $-170620000. The EBITDA ratio measures Merus BV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Merus BV’s operating margin was -418.45% while its return on assets stood at -26.67% with a return of equity of -61.08%.

In Q2, Merus BV’s quarterly earnings growth was a positive 0% while revenue growth was a negative 17.4%.

Merus BV’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-3.91 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Merus BV’s profitability.

Merus BV stock is trading at a EV to sales ratio of 6.6505 and a EV to EBITDA ratio of -2.3717. Its price to sales ratio in the trailing 12-months stood at 13.1869.

Merus BV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$363.62 million

Total Liabilities

$65.85 million

Operating Cash Flow

$0

Capital Expenditure

$349000

Dividend Payout Ratio

0%

Merus BV ended 2024 with $363.62 million in total assets and $0 in total liabilities. Its intangible assets were valued at $363.62 million while shareholder equity stood at $257.41 million.

Merus BV ended 2024 with $0 in deferred long-term liabilities, $65.85 million in other current liabilities, 5099000.00 in common stock, $-669896000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $101.10 million and cash and short-term investments were $265.05 million. The company’s total short-term debt was $1,610,000 while long-term debt stood at $0.

Merus BV’s total current assets stands at $283.13 million while long-term investments were $46.50 million and short-term investments were $163.95 million. Its net receivables were $3.81 million compared to accounts payable of $7.60 million and inventory worth $12.22 million.

In 2024, Merus BV's operating cash flow was $0 while its capital expenditure stood at $349000.

Comparatively, Merus BV paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$24.39

52-Week High

$27.7

52-Week Low

$12.03

Analyst Target Price

$46.44

Merus BV stock is currently trading at $24.39 per share. It touched a 52-week high of $27.7 and a 52-week low of $27.7. Analysts tracking the stock have a 12-month average target price of $46.44.

Its 50-day moving average was $24.27 and 200-day moving average was $20.13 The short ratio stood at 18.34 indicating a short percent outstanding of 0%.

Around 840.5% of the company’s stock are held by insiders while 8385.9% are held by institutions.